Devonian Health Group Inc. (GSD)
TSXV
Closed
Aug 25, 2026
Day's Range
11.0052 wk Range
0.1900Overview - GSD - Devonian Health Group Inc.
Key Statistics
Valuation
Enterprise Value
30.56M
P/E (Trailing)
‪-4.47‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪10.39‬
Price / Book
‪4.46‬
EV / EBITDA
‪-5.16‬
Profitability
Gross Margin
‪111.29%‬
Profit Margin
‪-204.08%‬
Operating Margin
‪-1,096.22%‬
Return on Assets
‪-24.50%‬
Return on Equity
‪-77.32%‬
Ownership
Shares Outstanding
2.78M
Float
2.10M
Held by Insiders
‪12.03%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪8.83‬
200-Day Avg
‪10.90‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - GSD - Devonian Health Group Inc.
Peers - GSD - Devonian Health Group Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TSXV.
Profile Summary - GSD - Devonian Health Group Inc.
About
Devonian Health Group Inc. is a dynamic entity in the biotechnology and pharmaceutical sector, focusing on the discovery, development, and commercialization of novel plant-based products. Known for its commitment to harnessing the therapeutic potential of botanical resources, Devonian Health Group Inc. operates…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
